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ABSTRACT 
Objective: Despite the broad pharmacological activity of gentamicin against a number of bacteria, it's very inadequate oral bioavailability due to 
poor intestinal membrane permeability has limited its formulation into oral dosage delivery system. This work was thus aimed at formulation and 
evaluation of gentamicin-loaded microemulsions based on preparation of lipid matrix for sustained release delivery. 
Methods: Oral gentamicin suspensions were prepared by emulsification method using Tween 80 as a mobile surfactant in the lipid matrix 
dispersion. The resultant oral suspensions were evaluated for mean particle size and morphology using a photomicrograph, encapsulation 
efficiency/entrapment, EE (%), dispersibility, pH and absolute drug content. Release study as a function of inhibition zone diameter (IZD) and in 
vitro release study was also carried out. The in vitro release study was performed in both simulated gastric fluid (pH 1.2) and simulated intestinal 
fluid (pH 7.2) respectively. The release data were analyzed mathematically according to zero order, first order and Higuchi equations. 
Results: The prepared suspensions were cream-white in colour, easily dispersed and well homogenized. Batch D, which had least amount of 
excipients incorporated into the lipid matrix showed clumped irregular-shaped and less free-flowing particles. The particle size was significantly 
influenced by lipid matrix combination ratio in the presence of a surfactant (p<0.05). The mean particle size diameters of the samples were 15.44 
mm, 10.64 mm, 4.12 mm, and 2.70 mm for batches A, B, C and D respectively. The values of EE obtained varied between 47% and 59% with Batch B 
exhibiting the highest value. The Higuchi model gave the best release kinetics result followed by zero order kinetics.  
Conclusion: Oral gentamicin prepared exhibited antibacterial properties against Klebsiella spp., Escherchia coli, Bacillus subtilis, Staphylococcus 
aureus, and Pseudomonas aeruginosa. The results suggest that a lipid matrix system could be useful as a sustained release oral delivery system of a 
poorly absorbable drug such as gentamicin. 
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Gentamicin sulphate is an aminoglycoside antibiotic commonly used 
topically in the control of severe Gram positive and Gram negative 
microbial infections especially in burns and wounds as well as for 
treating bone and soft tissue infections [1]. It is a polarized water-
soluble compound having very poor intestinal membrane 
permeability resulting in low oral bioavailability [2].  
Despite its benefits, bacterial membrane barriers and adverse effects 
such as nephrotoxicity, ototoxicity and neurotoxicity due to extended use 
had limited gentamicin daily dosage [3, 4]. A lot of researchers had 
employed various assay methods for determining some aminoglycosides 
including gentamicin in different delivery systems. These include: 
microbiological [5], polarographic [6], chemiluminescence [7], capillary 
electrophoresis [8], immunoassay [9], thin layer chromatographic [10], 
high performance liquid chromatographic [11], spectrofluorimetric [12], 
and spectrophotometric [13, 14] methods. 
Efforts had been made to determine the drug’s optimal therapeutic 
regimens in order to increase its overall efficacy while minimizing drug 
toxicity. These include; use of labrasol [1], liposomes [15], solidified 
reverse micellar drug delivery systems [16-18], and hydrogels [19, 20]. 
Gentamicin transdermal microgels had also been prepared by Nnamani 
et al. in 2013 [21]. Also, in 2013, gentamicin-gold nano spheres for 
antimicrobial drug delivery to Staphylococcal infected foci were 
formulated by Ahangari et al. [22]. Microsphere-gentamicin formulated 
by some workers was found to be effective as potential drug carrier 
which could be employed for treatment of E. coli K88 infection [23]. 
Microsphere formulations of gentamicin using bovine serum albumin 
(BSA) and glutaraldehyde as a polymer matrix and cross-linker 
respectively were prepared by Haswani et al. The products exhibited a 
significant increase in bioavailability which would permit a reduction in 
the frequency of gentamicin administration and would effectively reduce 
the drug’s dose related side effects [4].  
Quite a number of workers had employed various formulation 
technologies including self-micro-emulsifying delivery systems 
(SMEDDS) for delivery of some drugs like gentamicin, however, there 
seems to be no reported study on the use of the latter to achieve 
controlled the release of gentamicin and at the same time, evaluate its 
potentiality against different classes of microbes. This has, therefore, 
prompted us to formulate and evaluate gentamicin-loaded 
microparticles incorporated into lipid matrix formulation and 
surfactant combination with a view to achieving sustained release to 
enhance the intestinal permeability of gentamicin to achieve an 
improved antimicrobial activity.  
MATERIALS AND METHODS 
Materials 
The materials used were gentamicin, phospholipon 90g and 
polysorbate 80 (tween 80) purchased from Williams and sons Ltd, 
England, beeswax and dibasic potassium phosphate (BDH 
Chemicals), distilled water (Lion Water, University of Nigeria, 
Nsukka) and goat wax. The latter was extracted from goat fat 
purchased from the local market, placed in a pot and allowed to melt 
at 60-80 °C and subsequently allowed to cool. Other chemicals 
employed were of laboratory grade. 
Methods 
Preparation of gentamicin-loaded microemulsions based on 
formulation of lipid matrix 
Microemulsion loaded with gentamicin was prepared according 
to the formula in table (1). The lipid microparticles were 
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prepared using 1:1 (w/w) lipid matrices by a hot-emulsion 
technique using mixer followed by cooling at room temperature 
[24]. Four batches of SMEDDS were prepared for each lipid 
matrix according to the concentration of the gentamicin loaded 
(table 2). The lipid matrix incorporated progressively reduced as 
the drug component is increased. In each case, the lipid matrix 
was melted at 60 °C in a crucible, and the appropriate amount of 
gentamicin (for the loaded formulations) incorporated in 
sufficient volume of distilled water and brought to the same 
temperature with the lipid melt. The hot aqueous phase was 
poured into the melted lipid under high shear mixing using the 
mixer to give an o/w emulsion. The lipid microparticles 
suspension was obtained after cooling at room temperature for 
each lipid matrix ratio. 
 
Table 1: Formula for preparation of gentamicin-loaded microspheres 
Ingredients Amount 
Lipid matrix 10 % 
Gentamicin 0, 1, 3, 5 % 
Tween 80 1 % 
Waterto 50 g 
 
Table 2: Formulation of lipid matrix 
Batch number Tween 80 Drug (g) % composition (w/w) bees wax+goat wax Phospholipid Water to 
A 0.25 0.0 3.5 1.5 50g 
B 0.25 0.5 3.5 1.5 50g 
C 0.25 1.5 3.5 1.5 50g 
D 0.25 2.5 3.5 1.5 50g 
 
Characterization of the lipid microparticles 
Determination of pH 
A pH meter (Kent Industrial Measurements, England) was used to 
determine the pH of microparticulate suspension from each batch on 
weekly basis for 3 mo and the average values computed.  
Determination of absolute drug content 
The method used by Tahami et al. [25] was employed to evaluate the 
absolute drug content of the microparticles. A 0.5 g quantity of each 
batch of the suspended particles was placed in a 100 ml volumetric 
flask. The flask was made up to volume with distilled water and 
allowed to equilibrate at room temperature with intermittent shaking. 
This gave the stock solution. Nine solution batches having the following 
concentrations: 10 mg %, 20 mg %, 30 mg %, 40 mg %, 50 mg %, 60 mg 
%, 70 mg %, 80 mg %, 90 mg %, were made by diluting 10, 20, 30, 40, 50, 
60, 70, 80, 90 ml of the stock solution to 100 ml with distilled water. The 
corresponding absorbance of each of the solutions was obtained with a 
UV spectrophotometer (Jenway 6305 Spectrophotometer) at 370 nm 
wavelength. The Beer-Lambert’s plot was obtained from the results. 
Determination of EE (%)  
The values of EE (%) were determined by the method described by 
some researchers [26-28]. The theoretical drug content in the 
suspension was compared with the actual amount of the drug 
obtained from the drug content studies to get EE (%). This was 
calculated using the equation [26]: 







 × 100 
Preparation of simulated gastric fluid (SGF) 
SGF was prepared by dissolving sodium chloride in concentrated 
hydrochloride acid, mixing it properly and the volume made up to 1 
litre with distilled water and the pH adjusted to 1.2 [29]. 
Preparation of simulated intestinal fluid (SIF) 
SIF was prepared by dissolving 6.8 g of monobasic potassium 
phosphate in 250 ml of distilled water, mixed well followed by the 
addition of 77 ml, of 0.2 N sodium hydroxide and 500 ml of distilled 
water. This was mixed and made up to 1.0 l with distilled water and 
the pH adjusted to 7.2 [29]. 
Release study of gentamicin-loaded suspension 
Beer’s plot was obtained at the following concentrations: 0.2, 0.4, 0.6, 
0.8, 1.0 mg/ml for gentamicin in SGF at 341 nm. The USP XXII rotating 
paddle apparatus (Erweka germany) was used in the release study 
[27, 28, 30]. The dissolution medium consisted of 250 ml of freshly 
prepared SGF (pH 1.2) maintained at 37.1 °C. Dialysis as described by 
previous workers [24] was employed. A 0.5 g quantity of the 
formulated suspension was placed in the membrane and each securely 
tied with a thermo-resistant thread and then placed in the dissolution 
medium. The paddle at 100 rpm provided agitation. At predetermined 
time intervals, 5.0 ml portions of the dissolution medium were 
withdrawn, and their absorbance determined using the 
spectrophotometer above a wave length of 341 nm. The dissolved 
volume of dissolution medium was kept constant by replacing with 5 
ml of the fresh medium after each withdrawal to maintain sink 
condition. The amount of drug released at each time interval was 
determined with reference to the standard Beer’s plot for the drug in 
SGF. Release study was also similarly carried out in SIF. 
Release study as a function of IZD  
The agar diffusion method [24] was used in the determination of the 
IZD (mm) of the gentamicin-loaded lipid microparticles dispersion. 
Seeded agar plate was prepared by incorporating the specific 
microorganism and molten nutrient agar subsequently. It was left to 
stand until the seeded agar solidified. A cork borer of 8 mm diameter 
was used to bore holes at four ends of the seeded agar. The different 
gentamicin suspension batches were placed into the holes formed. 
The plate was carefully covered and incubated for 24 h. The 
microorganisms employed include Klebsiella spp, E. coli, B. subtilis, S. 
aureus, and P. aeruginosa (obtained as clinical isolates from the 
Pathology department of the University of Nigeria Teaching 
Hospital, Enugu, Nigeria). The determination was done in triplicates. 
Determination of particle size and morphology  
Particle size and morphology of the microparticles were determined 
by digital microscopy [26]. A 5 mg quantity of suspension was 
placed on a microscope slide. The slide was covered with a cover slip 
and observed using image-guided lens under a photomicroscope at a 
magnification of x 1000. Different particles from the suspension 
showing different orientations were measured and the mean values 
were taken. 
Centrifugation 
In order to estimate metastable system, the optimized lipid micro 
particles formulation was diluted with purified distilled water. The 
suspension was centrifuged at 3000 rpm for 15 min at 25 °C and 
observed for any change in homogeneity of the formulation.  
Statistical analysis 
All the experiments were carried out in triplicates (that is, n = 3). 
The data obtained were subjected to statistical analysis using a one-
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way analysis of variance (ANOVA) followed by Fisher (least 
significant difference) multiple comparison procedures to evaluate 
significant differences between groups. The differences were 
considered significant at p<0.05. 
RESULTS AND DISCUSSION 
The microparticles formed were spherical in shape and cream white 
in colour. Batch A which contained no drug showed very orderly and 
free-flowing particles. Batches B-D, with progressively decreased 
lipid matrix incorporated, showed clumped, irregular-shaped and 
less free-flowing particles. The mean particle dimensions of the 
batches A, B,C and D, as presented in table (3) also reduces in that 
order. As the drug content increased (that is, as the lipid matrix 
component decreased), the mean particle diameter also decreased. 
This direct influence of the lipid matrix on mean particle diameter is 
statistically significant (p<0.5). It was also observed that the free-
flow properties of all the batches of suspension were maintained at 
room temperature. It can, therefore, be inferred that the particle 
morphology and flow characteristics of the formed microparticles 
are influenced by the relative proportion of the lipid matrix content 
similar to earlier reported cases [17, 24]. The average pH values 
obtained were 6.92±0.22, 6.87±0.15, 7.01±0.18 and 6.95±0.09, for 
batches A–D, respectively. Statistically, there was no significant 
change in the values across the batches over a three months storage 
time (p>0.05). This indicates that during this storage time, there was 
no notable decomposition of any of the constituents of the 
preparations [12, 31]. This is an affirmation of the stability of the 
formulations. 
EE (%) was expressed as the percentage of the total amount of 
gentamicin used initially and the values are shown in table (3). The 
value of EE for gentamicin suspension per-batch was highest with 
batch B (59%). This can be attributed to a greater amount of drug 
incorporated into the lipid matrix which increases the diameter of 
the microparticles and EE by increasing the core available for 
entrapping a large amount of drug [26]. Statistically, the difference 
between EE values among the batches was significant (p<0.5).  
The presence of phospholipon 90G and polysorbate 80 in the 
suspensions increased their entrapment efficiency. While the latter 
component, being a hydrophilic surfactant promoted the 
solubilization of gentamicin within the core lipid matrix, the former 
gave rise to the formation of structured lipid matrices, which 
improved the entrapment of the drug in the core of the preparations. 
[24, 32]. The increase observed in the formulations is suggestive of 
their possible employment as sustained release delivery system. 
  
Table 3: Values of mean particle dimensions and EE (%) for all the SMEDDS batches 
Sample batch  Mean particle size diameter (µm) Perimeter (µm) Area (µm2) EE (%) 
A 15.44 49.05 184.59 - 
B 10.64 34.08  89.65 59 
C  4.13 13.29  14.08 52 
D  2.71  8.71  6.05 47 
n = 3; the presented results are the average of three (3) determinations 
 
When infinite dilution is done to the formulation, there is the 
possibility of phase separation, as microemulsions are formed at a 
particular concentration of oil, surfactant and water. For oral 
formulations, the process of dilution by the GI fluid will result in the 
gradual desorption of surfactant located at the global interface. The 
process is thermodynamically driven by the requirement of 
surfactant to maintain an aqueous phase concentration equivalent to 
its critical micelle concentration (CMC). In the present investigation 
(dispersibility test), distilled water was used as a dispersion medium 
because it is widely reported that there is no significant difference in 
the formulation prepared using nonionic surfactants, dispersed in 
either water, SGF or SIF [33-35].  
Formulations B and C containing 0.5% and 1.5% respectively passed the 
thermodynamic stability test whereas formulation D containing 2.5% 
did not pass the test as shown in the table (4). This may possibly be due 
to insufficient lipid matrix in the latter formulation, suggesting that the 
lipid possesses the ability to stabilize the preparation. 
  
Table 4: Results of thermodynamics stability test 
Suspension batch  % Drugs concentration Centrifugation test Inference 
A 0.0%   PASSED 
B 0.5%   PASSED 
C 1.5%   PASSED 
D 2.5%   FAILED 
n = 3; the presented results are the average of three (3) determinations 
 
Sink conditions are often violated when using conventional release 
method for dispersed systems. So, the method must be developed for 
lipid microparticles to separate the dissolved drugs from micro-
emulsion associated drugs before their determination. It has been 
reported that a dialysis method has been applied to gentamicin lipid 
microparticles, and a relatively high release rate was obtained in this 
study, a bulk-quilibrium reversed dialysis bag method was 
developed to allow an increase in the membrane surface area 
available for transport from the donor to the phase of the receiver 
and hence, to maintain sink condition in the donor phase by infinite 
dilution of the medium in the outer vessel. The small particle size of 
the microparticles also probably contributed to the increased 
release rate. 
Fig. (1) Represents the typical drug release plots from the dispersion 
for the different optimization variables. The degree and the mode of 
release of gentamicin from the prepared microparticles were analyzed 
mathematically by fitting the dissolution data into different kinetic 
models: zero order; first order, Higuchi’s equations, and coefficient of 
correlation (r2) values were calculated for the linear curves by 
regression analysis of the plots [28]. In SIF the data were best fitted to 
Higuchi equation. Batch D (containing 2.5% gentamicin), batch C 
(1.5% gentamicin), and batch B (0.5% gentamicin), exhibited r2 values 
of 0.940, 0.932 and 0.824, respectively.  
In SGF, the data were best fitted to Higuchi for batch D containing 
2.5% gentamicin with r2 value of 0.985. Batch B containing 0.5% 
gentamicin had r2 value of 0.984 while batch C containing 1.5% 
gentamicin had r2 value of 0.967. After incubating the seeded plate 
containing gentamicin samples for 24 h, the plates were observed 
and the IZD were measured planimetrically. It was observed that 
even in the absence of gentamicin, the microorganisms were 
inhibited (table 5). This implies that some of the excipients could 
exhibit some antibacterial activity. 
Adedokun et al. 




Fig. 1: Release profile of gentamicin from the microparticles in SIF and SGF, n = 3; the presented results are the average of three (3) 
determinations 
 
Table 5: Values of IZD for all the gentamicin preparations 
Microbes Gentamicin preparations and their IZD values  
Batch D Batch C Batch B Batch A 
 IZD (mm) Mean IZD 
(mm) 
 IZD (mm) Mean IZD 
(mm) 
 IZD (mm) Mean IZD 
(mm) 
 IZD (mm) Mean IZD 
(mm) 
Klebsiella sp 40.00  43.00  28.00  17.00  
 30.00  41.00  28.00  16.00  
 35.00 35.00 40.00 41.30 30.00  28.66 17.00 16.66 
E. coli. 36.00  5.00  30.00  14.00  
 37.00  35.00  30.00  14.00  
 36.00 36.33 36.00 35.33 28.00 29.33 14.00 14.00 
B. subtilis 30.00  29.00  26.00  20.00  
 32.00  28.00  26.00  20.00  
 30.00 30.66 30.00 29.00 27.00 26.33 23.00 21.00 





























n = 3; the presented results are the average of three (3) determinations 
 
From table (5), it can be seen that batch D had the highest activity 
and against P. aeruginosa. This expectedly shows that the higher the 
gentamicin incorporated, the greater the antibacterial activity. The 
result of the IZD measurement as presented in table (5) is in 
agreement with earlier findings that the quantity of drug loaded into 
the lipid matrix is directly proportional to the IZD produced [24, 31]. 
Statistically, the pharmacological effects exhibited on the microbes 
by different batches of the formulation vary significantly (p<0.05). 
From the result obtained, it can be inferred that lipid micro 
particulate suspensions prepared by SMEDDS using optimized 
variables have antibacterial properties on the organisms. 
CONCLUSION 
From this study, the higher the lipid matrix incorporated the higher 
the particle size diameter as well as EE (%). Furthermore, the critical 
process in the preparation by the self-micro-emulsifying gentamicin 
suspension played an important role in the in vitro drug release. It was 
shown that the release of gentamicin from dispersion followed zero 
order and Higuchi release kinetics rather than first order release. 
Sustained release gentamicin suspension can be prepared using the 
above-stated optimization variables as an increase in the 
concentration of the lipid matrix would increase the tendency of its 
particle entrapment.  
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